These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 18515867)

  • 1. The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement.
    Hunzelmann N; Genth E; Krieg T; Lehmacher W; Melchers I; Meurer M; Moinzadeh P; Müller-Ladner U; Pfeiffer C; Riemekasten G; Schulze-Lohoff E; Sunderkoetter C; Weber M; Worm M; Klaus P; Rubbert A; Steinbrink K; Grundt B; Hein R; Scharffetter-Kochanek K; Hinrichs R; Walker K; Szeimies RM; Karrer S; Müller A; Seitz C; Schmidt E; Lehmann P; Foeldvári I; Reichenberger F; Gross WL; Kuhn A; Haust M; Reich K; Böhm M; Saar P; Fierlbeck G; Kötter I; Lorenz HM; Blank N; Gräfenstein K; Juche A; Aberer E; Bali G; Fiehn C; Stadler R; Bartels V;
    Rheumatology (Oxford); 2008 Aug; 47(8):1185-92. PubMed ID: 18515867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
    J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis.
    Moinzadeh P; Aberer E; Ahmadi-Simab K; Blank N; Distler JH; Fierlbeck G; Genth E; Guenther C; Hein R; Henes J; Herich L; Herrgott I; Koetter I; Kreuter A; Krieg T; Kuhr K; Lorenz HM; Meier F; Melchers I; Mensing H; Mueller-Ladner U; Pfeiffer C; Riemekasten G; Sárdy M; Schmalzing M; Sunderkoetter C; Susok L; Tarner IH; Vaith P; Worm M; Wozel G; Zeidler G; Hunzelmann N;
    Ann Rheum Dis; 2015 Apr; 74(4):730-7. PubMed ID: 24389298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis.
    Sobanski V; Giovannelli J; Allanore Y; Riemekasten G; Airò P; Vettori S; Cozzi F; Distler O; Matucci-Cerinic M; Denton C; Launay D; Hachulla E;
    Arthritis Rheumatol; 2019 Sep; 71(9):1553-1570. PubMed ID: 30969034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database.
    Lescoat A; Huang S; Carreira PE; Siegert E; de Vries-Bouwstra J; Distler JHW; Smith V; Del Galdo F; Anic B; Damjanov N; Rednic S; Ribi C; Bancel DF; Hoffmann-Vold AM; Gabrielli A; Distler O; Khanna D; Allanore Y;
    JAMA Dermatol; 2023 Aug; 159(8):837-847. PubMed ID: 37378994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
    Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
    Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
    Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
    Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Older age onset of systemic sclerosis - accelerated disease progression in all disease subsets.
    Moinzadeh P; Kuhr K; Siegert E; Mueller-Ladner U; Riemekasten G; Günther C; Kötter I; Henes J; Blank N; Zeidler G; Pfeiffer C; Juche A; Jandova I; Ehrchen J; Schmalzing M; Susok L; Schmeiser T; Sunderkoetter C; Distler JHW; Worm M; Kreuter A; Krieg T; Hunzelmann N;
    Rheumatology (Oxford); 2020 Nov; 59(11):3380-3389. PubMed ID: 32333004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and outcome of 1054 patients with Systemic Sclerosis: analysis of Reuma.pt/SSc registry.
    Freitas R; Martins P; Dourado E; Santiago T; Guimarães F; Fernandes BM; Garcia S; Samões B; Pinto AS; Gonçalves N; Lourenço MH; Costa E; Rocha M; Couto M; Duarte AC; Araújo F; Cordeiro I; Godinho F; Resende C; Salvador MJ; Cordeiro A; Santos MJ
    ARP Rheumatol; 2022; 1(1):21-29. PubMed ID: 35633574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences Sustained Between Diffuse and Limited Forms of Juvenile Systemic Sclerosis in an Expanded International Cohort.
    Foeldvari I; Klotsche J; Kasapcopur O; Adrovic A; Terreri MT; Sakamoto AP; Stanevicha V; Sztajnbok F; Anton J; Feldman B; Alexeeva E; Katsicas M; Smith V; Avcin T; Marrani E; Kostik M; Lehman T; Sifuentes-Giraldo WA; Vasquez-Canizares N; Appenzeller S; Janarthanan M; Moll M; Nemcova D; Patwardhan A; Santos MJ; Sawhney S; Schonenberg-Meinema D; Battagliotti C; Berntson L; Bica B; Brunner J; Costa-Reis P; Eleftheriou D; Harel L; Horneff G; Kaiser D; Kallinich T; Lazarevic D; Minden K; Nielsen S; Nuruzzaman F; Uziel Y; Helmus N; Torok KS
    Arthritis Care Res (Hoboken); 2022 Oct; 74(10):1575-1584. PubMed ID: 33787070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
    Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
    Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
    Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
    Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
    Perera A; Fertig N; Lucas M; Rodriguez-Reyna TS; Hu P; Steen VD; Medsger TA
    Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State-of-the-art technologies provide new insights linking skin and blood vessel abnormalities in SSc-related disorders.
    Dinsdale G; Wilkinson S; Wilkinson J; Moore TL; Manning JB; Berks M; Marjanovic E; Dickinson M; Herrick AL; Murray AK
    Microvasc Res; 2020 Jul; 130():104006. PubMed ID: 32320708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis.
    Meyer OC; Fertig N; Lucas M; Somogyi N; Medsger TA
    J Rheumatol; 2007 Jan; 34(1):104-9. PubMed ID: 17117486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
    Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP
    Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domains and outcome measures for the assessment of limited cutaneous systemic sclerosis: an international collaborative scoping review.
    Lescoat A; Sandler RD; Zimmermann F; Roofeh D; Hughes M; Pauling JD; Murphy SL; Chen YT; Townsend W; Buch MH; Khanna D
    Rheumatology (Oxford); 2022 Aug; 61(8):3132-3148. PubMed ID: 35094049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and predictors of hand involvement in Thai patients with systemic sclerosis.
    Wangkaew S; Sivasomboon C; Leungwatthananon W; Kasitanon N; Louthrenoo W
    Int J Rheum Dis; 2018 Jan; 21(1):240-248. PubMed ID: 27456855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic sclerosis sine scleroderma and limited cutaneous systemic sclerosis: similarities and differences.
    Simeón-Aznar CP; Tolosa-Vilella C; Gabarró-Juliá L; Campillo-Grau M; Guillén Del Castillo A; Fonollosa-Plá V; Vilardell-Tarrés M
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-33-40. PubMed ID: 24776173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.